About 5 results found for searched term "BPD" (0.12 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M3539 | Verteporfin (CL 318952) | YAP |
| CL 318952; BPD-MA | ||
| Verteporfin (CL 318952) is a photosensitizer for photodynamic therapy to eliminate the abnormal blood vessels in the eye associated with conditions such as age-related macular degeneration. Verteporfin (CL 318952) is a YAP inhibitor that disrupts YAP-TEAD interactions, and it is also an inhibitor of autophagy. | ||
| M8352 | BPD | Others |
| BPD inhibits LPS-induced NF-kB signaling by inactivation of TAK-1. | ||
| M21666 | Recombinant Mouse IL-18BPd (HEK293, C-Fc) | Cytokines and Growth Factors |
| Interleukin-18 Binding Protein Isoform d | ||
| Recombinant Mouse Interleukin 18 binding protein (IL-18BP) is a physiological inhibitor that acts through binding to the receptor-binding site of IL-18. Recombinant Mouse Interleukin-18 Binding Protein Isoform d is produced by our Mammalian expression system and the target gene encoding Thr29-Ala193 is expressed with a human IgG1 Fc tag at the C-terminus. | ||
| M29887 | BPDBA | GABA Receptor |
| BPDBA is a selective and noncompetitive betaine/GABA transporter (BGT-1) inhibitor with IC50s of 20 μM and 35 μM against human BGT-1 and mouse GAT2, respectively. | ||
| M25019 | Pivekimab | IL Receptor/Related |
| Pivekimab is a human IgG1 monoclonal antibody targeting interleukin 3 (IL-3) and CD123. Pivekimab can be used in the study of blastocytic plasmacytoid dendritic cell tumor (BPDCN). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
